Hepatitis B Vaccine and Immunoglobulin: Key Concepts

Area of Science:

• Immunology
• Vaccinology
• Hepatology

Background:

• Hepatitis B virus (HBV) immunization is a safe, routine global practice.
• Vaccination aims to induce an immune response to prevent HBV replication.
• Vaccine efficacy and safety depend on immunological and clinical factors.

Purpose of the Study:

• To review host immune response to HBV vaccination (immunogenicity).
• To discuss vaccine efficacy, safety, and booster dosing.
• To explore HBV vaccine development, novel strategies, and therapeutic vaccination.

Main Methods:

• Literature review of HBV vaccine research.
• Analysis of preclinical and clinical development pathways.
• Discussion of regulatory recommendations for vaccine development.

Main Results:

• HBV vaccination elicits immune responses influencing efficacy and safety.
• Novel strategies include pre-S antigens, increased dose, accelerated schedules, and adjuvants.
• Therapeutic vaccination aims for T cell and humoral responses against HBV antigens.

Conclusions:

• Ongoing research focuses on improving HBV vaccine efficacy and safety.
• Novel strategies and therapeutic vaccination offer promising avenues for HBV control.
• Comprehensive understanding of vaccine development is crucial for public health.